Eden Expands Metabolic Health Access Services with NAD⁺ via Injections, Patch, and Nasal-Spray Formats

Three clinician-guided options offer flexible, non-oral delivery paths for adults exploring NAD⁺ as part of their wellness routines.

DENVER, May 29, 2025 /PRNewswire/ -- Eden, the leading health platform connecting individuals with independent licensed providers and pharmacies focused on metabolic health, today announced the nationwide availability of its NAD⁺ access program. The program includes subcutaneous injections, a once-weekly transdermal patch (Ionto STAT™), and a rapid-absorbing nasal spray. These options give adults new ways to consult with clinicians about whether NAD⁺ may complement their health and wellness goals.

Nicotinamide adenine dinucleotide (NAD⁺) is a coenzyme found in all living cells that plays a role in cellular metabolism. Scientific literature suggests that NAD⁺ contributes to essential biological functions, including mitochondrial energy production, DNA repair, and cellular stress responses. NAD⁺ levels are known to decline with age, sparking growing interest in its potential role in aging-related cellular processes.

Through Eden's platform, adults in all 50 states can access clinician consultations to determine if NAD⁺ is appropriate for their individual needs. Provider-guided protocols may include non-oral formats that are intended to support general wellness, particularly cellular functions related to metabolism and healthy aging. These offerings are available through licensed providers and compounding pharmacies, and are not approved by the FDA for any disease-specific use.

"Many people are exploring NAD⁺ as a supplement to support cellular processes associated with energy metabolism and aging," said Adam McBride, CEO and co-founder of Eden. "Our platform ensures this exploration happens under clinician supervision, with flexibility and accountability."

"We believe access and accountability go hand in hand," said Josh Khan, president and co-founder of Eden. "Our network partner providers set realistic expectations. While some individuals may report subjective improvements over time, outcomes vary widely and depend on many personal and clinical factors. Providers monitor patient response and adjust protocols based on evolving research and patient goals."

Monthly plans begin at $119, terms apply. Existing Eden members can discuss NAD⁺ options during routine check-ins. Learn more at tryeden.com.

About Eden

Eden is a health company that connects individuals with licensed doctors, compounding pharmacies, and nutrition solutions designed to support metabolic health. Through a seamless online experience, Eden helps patients explore personalized treatment options, offering a convenient approach to overall wellness support.

Disclaimer: NAD⁺ formulations accessed through Eden's network are available via licensed healthcare providers and compounding pharmacies. These compounds are not approved by the Food and Drug Administration (FDA) to diagnose, treat, cure, or prevent any disease. Individual results may vary. These statements have not been evaluated by the FDA.

SOURCE Eden